Funding
|
Analytical BioSciences and Metabolomics, Division of Systems Biomedicine and Pharmacology, Leiden University.
|
|
|
European Union’s Horizon 2020 research and innovation programme under grant agreement No 668738.
|
|
U.S. Department of Energy, Offices of Advanced Scientific Computing Research and the Biological and Environmental Research as part of the Scientific Discovery Through Advanced Computing program, grant no. DE-SC0010429
|
|
This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (Grant agreement No. 757922)”
|
|
This project has received funding from the Open Multiscale Systems Medicine (OpenMultiMed), a COST (European Cooperation in Science and Technology) Action, under the European Union’s Framework Programme Horizon 2020 research and innovation programme (Grant agreement no. CA15120)”
|
Nathan E. Lewis has been supported by NIGMS (R35 GM119850) and the Novo Nordisk Foundation (NNF10CC1016517). Anne Richelle has been supported by the Lilly Innovation Fellows Award.